Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
March 31, 2007
Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function
Sharlene M Day, Margaret V Westfall, Joseph M Metzger
The Journal of Clinical Investigation
|
March 1, 2022
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
Sharlene M Day, Jil C Tardiff, E Michael Ostap
JACC. Case Reports
|
July 28, 2021
Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic Cardiomyopathy
Alejandro E de Feria, Kimberly Y Lin, Sharlene M Day
American Journal of Cardiovascular Disease
|
June 21, 2013
Prevalence of aortic dilation in hypertrophic cardiomyopathy
Renuka Jain, Adam Helms, Sharlene M Day, et al.
Thrombosis and Haemostasis
|
September 8, 2004
Murine thrombosis models
Sharlene M Day, Jennifer L Reeve, Daniel D Myers, et al.
Journal of Molecular and Cellular Cardiology
|
December 15, 2018
MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy
Thomas S O'Leary, Julia Snyder, Sakthivel Sadayappan, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy
Graham A Branscom, Michael Morley, Jonathan J Herrera, et al.
Circulation Research
|
April 3, 2004
Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations
Pierre Coutu, Christina N Bennett, Elizabeth G Favre, et al.
Physiological Reports
|
May 2, 2024
High-intensity exercise training using a rotarod instrument (RotaHIIT) significantly improves exercise capacity in mice
Jonathan J Herrera, Christopher M McAllister, Danielle Szczesniak, et al.
Cardiovascular Research
|
July 19, 2008
Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction
Nathan J Palpant, Sharlene M Day, Todd J Herron, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Journal of Molecular Medicine (Berlin, Germany)
|
March 31, 2007
Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function
Sharlene M Day, Margaret V Westfall, Joseph M Metzger
The Journal of Clinical Investigation
|
March 1, 2022
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
Sharlene M Day, Jil C Tardiff, E Michael Ostap
JACC. Case Reports
|
July 28, 2021
Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic Cardiomyopathy
Alejandro E de Feria, Kimberly Y Lin, Sharlene M Day
American Journal of Cardiovascular Disease
|
June 21, 2013
Prevalence of aortic dilation in hypertrophic cardiomyopathy
Renuka Jain, Adam Helms, Sharlene M Day, et al.
Thrombosis and Haemostasis
|
September 8, 2004
Murine thrombosis models
Sharlene M Day, Jennifer L Reeve, Daniel D Myers, et al.
Journal of Molecular and Cellular Cardiology
|
December 15, 2018
MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy
Thomas S O'Leary, Julia Snyder, Sakthivel Sadayappan, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy
Graham A Branscom, Michael Morley, Jonathan J Herrera, et al.
Circulation Research
|
April 3, 2004
Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations
Pierre Coutu, Christina N Bennett, Elizabeth G Favre, et al.
Physiological Reports
|
May 2, 2024
High-intensity exercise training using a rotarod instrument (RotaHIIT) significantly improves exercise capacity in mice
Jonathan J Herrera, Christopher M McAllister, Danielle Szczesniak, et al.
Cardiovascular Research
|
July 19, 2008
Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction
Nathan J Palpant, Sharlene M Day, Todd J Herron, et al.
Page
of 13